Specialty drug spend is the single fastest growing healthcare expense. Recognizing the potential clinical value of these drugs, plan sponsors want to provide them to their enrollees—but to maintain an affordable, sustainable benefit in this rapidly changing environment, they must also control costs... Read more
Charlie Health
15 followers
Madrigal Pharmaceuticals
10 followers
Exo
3 followers
Fennec Pharmaceuticals
2 followers
The American Institute of Balance
1 follower
Bristol-Myers Squibb
316 followers
Lundbeck
52 followers
Alnylam Pharmaceuticals
50 followers
NYU Langone Health
49 followers
Syneos Health
38 followers
Catalent
34 followers
Parexel
21 followers